Tuberculosis has become a major health problem, in particular with the emergence of extremely drug resistant tuberculosis (XDRTB). In our search for new therapeutic leads against TB, we isolated a new triterpene (1) from the plant Rhus taitensis collected in Papua New Guinea. Tetrahydroxysqualene (1) was isolated using bioassay-guided fractionation of the methanolic extract of R. taitensis leaves and twigs. The structure of tetrahydroxysqualene (1) was elucidated on the basis of HRESIMS and 1D and 2D NMR spectra. Tetrahydroxysqualene (1) exhibited anti-tuberculosis activity with an MIC of 10.0 μg/mL while showing only modest cytotoxicity.Tuberculosis, caused by the bacterial pathogen Mycobacterium tuberculosis, has become a major global health threat, especially in developing nations.1 TB therapy requires long treatment regimens and patient compliance is difficult, 2 and failure of patients to comply with therapy has led to the emergence of multi drug resistant TB (MDRTB) and extremely drug resistant TB (XDRTB). 2, 3 There is an ever-growing need for new therapeutics for treatment of TB, especially for HIV/TB patients.4Over the past decades, natural products have played an important role as sources of secondary metabolites with potential as lead compounds for drug discovery. 5 In our effort to discover new therapeutic leads against TB, we screened a natural products library constructed of plant extract fractions from Papua New Guinea plants. Plant extracts were fractionated on HP20SS, which is a reversed-phase polystyrene-based adsorbent (See Experimental). The subsequent fractions were formatted into 96-well plates for screening. After screening the HP20SS library, we identified a TB inhibitory HP20SS fraction from Rhus taitensis Guill. (Anacardiaceae). A large scale extraction and bioassay-guided fractionation yielded one new triterpene, tetrahydroxysqualene (1) as the active component and the known 3β,22,25-trihydroxylupane. 6 The latter was not active against TB.The genus Rhus, also known by the common name sumac, contains over 250 described species of flowering plants, and the biological activities of Rhus spp. extracts have recently been reviewed. 7,8 More recent reports include detailed studies on the anti-HIV activity of